Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo H Goulart

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer|June 2, 2009
Medical interpreter knowledge of cancer and cancer clinical trialsKaren Donelan, Karin Hobrecker, Lidia Schapira, et al.
Head & Neck|December 29, 2017
Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignanciesCristina P Rodriguez, Renato G Martins, Christina Baik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2010
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlationLaurie L Carr, David A Mankoff, Bernardo H Goulart, et al.
JAMA|November 4, 2004
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trialsThomas G Roberts, Bernardo H Goulart, Lee Squitieri, et al.
Cancer|April 19, 2018
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trialMargaret K Guerriero, Mary W Redman, Kelsey K Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2016
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHNLaura Q M Chow, Chihiro Morishima, Keith D Eaton, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer|June 2, 2009
Medical interpreter knowledge of cancer and cancer clinical trialsKaren Donelan, Karin Hobrecker, Lidia Schapira, et al.
Head & Neck|December 29, 2017
Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignanciesCristina P Rodriguez, Renato G Martins, Christina Baik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2010
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlationLaurie L Carr, David A Mankoff, Bernardo H Goulart, et al.
JAMA|November 4, 2004
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trialsThomas G Roberts, Bernardo H Goulart, Lee Squitieri, et al.
Cancer|April 19, 2018
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trialMargaret K Guerriero, Mary W Redman, Kelsey K Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2016
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHNLaura Q M Chow, Chihiro Morishima, Keith D Eaton, et al.
Pageof 1